Share this article

Global collaboration is crucial for lymphology and filariology

David Addiss
11 February 2014

<p>‘New trial with antibiotics brings hope to elephantiasis sufferers’ declared a recent press release from a prominent university in the UK. Researchers reported that lymphoedema stage (but not limb circumference or the incidence of acute inflammatory episodes) had been significantly reduced in eight patients from a filariasis-endemic area of Ghana one year after a six-week course of the antibiotic doxycycline (Debrah et al, 2006). The substantial publicity that surrounded this announcement (BBC, 2006), described as a ‘breakthrough’ by one of the investigators, reflects how deeply people with lymphoedema and their carers yearn for a definitive ‘cure.’</p>

Free for all healthcare professionals

Sign up to the Wounds Group journals

By clicking ‘Subscribe’, you are agreeing that the Wounds Group are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our privacy policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.

I am not a healthcare professional.